(Q51039388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Sang Hoon Ahn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Seto WK

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

2

Man-Fung Yuen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

3

Henry Lik-Yuen Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

9

Vincent Wai-Sun Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

8

Chien-Jen Chen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Hwai-I Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Pei-Jer Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Do-Young Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

REACH-B Working Group

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

14 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

568-574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus infection

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

How to predict HCC development in patients with chronic B viral liver disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Epidemiological characteristics and risk factors of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970077-8

7 January 2021

10.1016/S1470-2045(11)70077-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497551%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference